New drug tested for debilitating nerve disease
NCT ID NCT04658472
Summary
This study tested an experimental drug called SAR445088 in adults with CIDP, a rare condition that causes progressive weakness and numbness. The main goal was to see if the drug could control the disease and prevent relapses in different groups of patients, including those who do not respond well to standard treatments. Researchers also monitored the drug's safety and how well it was tolerated over a long period.
This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes NO responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for CHRONIC INFLAMMATORY DEMYELINATING POLYRADICULONEUROPATHY are added.
By submitting, you agree to our Terms of use
Contacts and locations
Show contact details
Enter your email to view the contact information for this study.
By submitting, you agree to our Terms of use
Locations
-
Columbia University Site Number : 8400005
New York, New York, 10032, United States
-
Investigational Site Number : 1240001
Gatineau, Quebec, J8Y 1W2, Canada
-
Investigational Site Number : 1240002
Québec, G1J 1Z4, Canada
-
Investigational Site Number : 1560001
Shanghai, 200040, China
-
Investigational Site Number : 1560002
Fuzhou, 350001, China
-
Investigational Site Number : 1560004
Wuhan, 430030, China
-
Investigational Site Number : 2500001
Marseille, 13385, France
-
Investigational Site Number : 2500002
Nice, 06002, France
-
Investigational Site Number : 2500003
Bordeaux, France
-
Investigational Site Number : 2500004
Garches, 92380, France
-
Investigational Site Number : 2500005
Le Kremlin-Bicêtre, 94275, France
-
Investigational Site Number : 2760001
Düsseldorf, 40225, Germany
-
Investigational Site Number : 2760002
Göttingen, 37075, Germany
-
Investigational Site Number : 2760003
Essen, 45147, Germany
-
Investigational Site Number : 2760004
Tübingen, 72076, Germany
-
Investigational Site Number : 3800001
Milan, 20132, Italy
-
Investigational Site Number : 3800002
Rome, Lazio, 00168, Italy
-
Investigational Site Number : 3800003
Genova, 16132, Italy
-
Investigational Site Number : 3800005
Rozzano, Milano, 20089, Italy
-
Investigational Site Number : 5280001
Amsterdam, 1105AZ, Netherlands
-
Investigational Site Number : 5280002
Utrecht, 3584 CX, Netherlands
-
Investigational Site Number : 6160001
Lublin, Lublin Voivodeship, 20-954, Poland
-
Investigational Site Number : 6880001
Belgrade, 11000, Serbia
-
Investigational Site Number : 6880002
Belgrade, 11000, Serbia
-
Investigational Site Number : 6880003
Niš, 18000, Serbia
-
Investigational Site Number : 7240001
Barcelona, Barcelona [Barcelona], 08041, Spain
-
Investigational Site Number : 7240002
Barcelona, Barcelona [Barcelona], 08035, Spain
-
Investigational Site Number : 7240003
Valencia, 46026, Spain
-
The University of Kansas Clinical Research Center Site Number : 8400003
Fairway, Kansas, 66205, United States
-
University of California Irvine Site Number : 8400002
Orange, California, 92868, United States
-
University of Minnesota Site Number : 8400006
Minneapolis, Minnesota, 55414, United States
-
University of Southern California Site Number : 8400004
Los Angeles, California, 90033, United States
Conditions
Explore the condition pages connected to this study.